Arnuity Ellipta FDA Approval History
FDA Approved: Yes (First approved August 20, 2014)
Brand name: Arnuity Ellipta
Generic name: fluticasone furoate
Dosage form: Inhalation Powder
Treatment for: Asthma, Asthma, Maintenance
Arnuity Ellipta (fluticasone furoate inhalation powder) is a once-daily inhaled corticosteroid for the maintenance treatment of asthma.
Development Timeline for Arnuity Ellipta
|May 24, 2018||ApprovalGSK Receives FDA Approval of Arnuity Ellipta for Asthma in Children From 5 Years of Age|
|Aug 21, 2014||ApprovalFDA Approves Arnuity Ellipta (fluticasone furoate) for the Treatment of Asthma|
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.